13F filing recap · Q3 2025
What did Engaged Capital buy in Q3 2025?
Reported stock-position changes between this filing and the previous one.
Stock value
$407.63M
Positions
9
Estimated turnover
20.3%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
Engaged Capital opened new positions in Cognex Corporation and Blackline, Inc. It also slightly increased its stakes in V. F. Corporation, Yeti Holdings, Gxo Logistics, Portillo'S Inc., and Brc Inc., while slightly trimming Evolent Health.